Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FAPI-46 × Gastrointestinal × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC) 1

Interventions

Oxaliplatin 67 Specimen Handling 66 Fluorouracil 63 Bevacizumab 61 Gemcitabine 59 Magnetic Resonance Spectroscopy 54 Leucovorin 49 pembrolizumab 43 Nivolumab 42 Capecitabine 40 Biopsy 39 Cisplatin 36 Paclitaxel 30 Irinotecan 28 130-nm albumin-bound paclitaxel 28 durvalumab 27 Cetuximab 27 Taxes 23 Albumin-Bound Paclitaxel 23 atezolizumab 22 dehydroftorafur 21 Carboplatin 21 Radiotherapy 18 sintilimab 15 lenvatinib 15 Radiation 15 Folfox protocol 15 tislelizumab 12 X-Rays 12 Trastuzumab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06659705 2026-04-15

INDIGO-FAPI

Institut Curie

Phase 2 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡